ArticleCancer research2021

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Hoi Wing Leung et al.PubMed ↗Publisher ↗

No numbers read from the abstract.